Immunogenicity and Safety Study of Adjuvanted SARS-CoV-2 (SCB-2019) Vaccine in Adultsin China
Clinical trial NCT04954131 · UNKNOWN
Trial details
- NCT number
- NCT04954131
- Sponsor
- Zhejiang Clover Biopharmaceuticals, Inc.
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-08-10
- Primary completion
- 2021-11-15
- Enrollment
- 766
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.